Many practices are promoting GLP-1s as weight loss drugs for people without diabetes
Al-Tabakha MM
Month 3 (Weeks 8-12 post-last injection): Cycles are typically stabilizing by now as hormones adjust to your new body weight
A summary of clinical trials to include drug, dosing strategy, sample size, primary outcome measurements, risk reduction, date of publication, and conclusions is found in Table 1 [103,104,105,106,107,108,109,110,111,112]
Promoting cell proliferation and neurogenesis In addition to its hormonal and neuropeptide activity, GLP-1 also is considered a growth factor that regulates cell growth and differentiation, and promotes interruption of pro-apoptotic processes (165)
The gastrointestinal symptoms experienced during GLP-1 therapy primarily result from altered motility rather than enzyme deficiency